SCHEMBL24690554

SCHEMBL24690554

NCC(=O)N[C@H](CO)C[C@@H]1CCNC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19924782 0.84 CTSL (0.36) —
SCHEMBL7417089 0.84 CTSL (0.36) —
SCHEMBL6064485 0.84 CTSL (0.36) —
SCHEMBL24690561 0.82 — —
SCHEMBL30913963 0.81 CCR2 (0.49) —
SCHEMBL22758567 0.81 — —
SCHEMBL24113375 0.80 CTSS (0.46) —
SCHEMBL25008065 0.79 NAAA (0.42) —
SCHEMBL23506393 0.79 CTSL (0.39) —
SCHEMBL21772494 0.77 L3MBTL1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022256434-A1 PROTEASE INHIBITORS AS ANTIVIRALS ACEA Therapeutics, Inc. (US) 2022-12-08 — — WO disclosed
Send feedback